By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


Linde/Praxair Pieces Appear to Fall into Place with FTC Review

The U.S. Federal Trade Commission’s decision on the $45 billion Linde/Praxair transaction could come very soon, according to a person close to the situation.featured

LyondellBasell is the Likely Buyer of Linde’s La Porte Plant

Linde’s HYCO plant in La Porte, Texas, along with employee contracts are going to be sold to LyondellBasell as Linde/Praxair aim to save their multi-billion merger, a person with knowledge of the matter told CTFN.featured

NEX Group and CME Hope for Quiet CMA Comment Period

With additional reporting by Diane Alter – The UK’s Competition and Markets Authority’s review of the acquisition of NEX Group by CME was opened on September 13, after several months of pre-notification discussions between the parties and the regulator.featured

Tronox Seen Shifting Focus from FTC Challenge to Divestiture

Following its defeat in federal court on September 5, Tronox is focusing on a divestiture package that would satisfy federal antitrust regulators while it pursues the lengthy legal challenge to the U.S. Federal Trade Commission’s administrativefeatured

Fresenius Continues to Advance NxStage Acquisition

Fresenius is on track to close its acquisition of NxStage on the timeline that the parties have indicated to the market, CTFN has learned.featured

Uncertainty Looms over China’s Regulatory Reshuffle

The regulatory reform announced by the Chinese government earlier this year, which lead to the creation of a “super regulator,” the State Administration for Market Regulation (SAMR), is now starting tofeatured

Linde/Praxair Present Additional Remedies to FTC

Linde and Praxair have agreed to offer additional remedies to the U.S. Federal Trade Commission as the industrial gas firms aim to save their $83 billion all-stock merger, CTFN has learned.featured

State AG Appetite for Aetna/CVS Suit Waning

A person close to the working group of 18 state attorneys general investigating the $69 billion Aetna/CVS deal told CTFN that a Medicare Part D divestiture is sufficient for most AGs to accept the Department of Justice’s expected decision to clear the deal.featured

Update: Rockwell Collins/United Technologies

When United Technologies meets privately with investors this week it will reiterate that its $30 billion acquisition of Rockwell Collins is on track to close this quarter.featured

First Look: Stryker Acquisition of K2M

Stryker’s $1.4 billion acquisition of spinal device company K2M Group is expected to clear Hart-Scott-Rodino without concerns, antitrust attorneys familiar with the space told CTFN.featured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.